A typical 12-month plan involves an initial consultation, an initial treatment, a 2-week review, then 2 to 4 follow-up treatments at appropriate intervals across the year, each with their own review. The plan is reviewed at 12 months and adjusted for the second year. Outcomes develop progressively across these visits rather than appearing in a single session.
Why 12 Months is the Useful Window
Cosmetic injectable outcomes are not built in single appointments. Anti-wrinkle treatment relaxes muscles, but the visible reduction in lines develops as the muscle bulk reduces over consistent treatment cycles. Filler treatment adds volume, but the integration with surrounding tissue and the patient’s response to the change settles across weeks and months.
A single appointment is the start of an outcome, not the outcome itself. Many patients new to treatment expect that one session will produce the result they want. Conservative practice sets a different expectation: outcomes develop across multiple appointments, with adjustment based on the patient’s response and the practitioner’s observation of how the anatomy is changing.
12 months is the useful window because it covers most of the cycle for the common treatment areas. Anti-wrinkle treatment in the upper face cycles every 12 to 16 weeks, so 12 months covers 3 to 4 sessions. Filler treatment may be planned across 1 to 3 sessions in a year, with the duration of effect typically extending into year two and beyond.
Months 1 to 3: Consultation and Initial Treatment
The 12-month arc begins with consultation. AHPRA September 2025 guidance requires a cooling-off period for new patients between consultation and treatment, so the first appointment is typically a structured assessment without treatment.
The consultation produces a treatment plan. For patients new to injectable treatment, the plan is typically conservative: starting with a single area or modest treatment to assess the patient’s response before committing to broader treatment. The initial treatment is scheduled at a subsequent appointment.
The initial treatment itself is structured around the consultation findings. Dosing is calibrated to the patient’s anatomy. Technique is calibrated to the area. The treatment is documented, photographed, and the 2-week review is scheduled. By the end of month 3, the patient has had the consultation, the initial treatment, and the first review.
Months 3 to 6: Settling and First Adjustment
After the 2-week review, the patient has 8 to 12 weeks to live with the result before the next intervention. This is a deliberate part of the plan. The patient experiences the settled outcome in their daily life, develops a view of what they like and what they would adjust, and brings that information to the next appointment.
For anti-wrinkle treatment, the next appointment falls roughly at the 12 to 16 week mark, which is the standard rebooking interval. For filler treatment, the next intervention may not be until 4 to 6 months, depending on the area and the original plan.
The second treatment incorporates lessons from the first. The dose may be adjusted up or down. The technique may be refined. New areas may be added if the consultation discussed them. The review structure repeats: 2-week review for anti-wrinkle, longer review interval for filler. By month 6, the patient has had 2 treatments and 2 reviews.
Months 6 to 9: Refinement
The middle third of the year is the period during which the outcomes start to feel established. The muscle bulk in treated anti-wrinkle areas has typically begun to reduce, leading to softer-looking static lines and a longer relative duration of effect. Filler placed earlier in the year has settled and integrated.
This is the period during which patients sometimes notice that the treatment outcomes are ‘real’ in a different way than they were after the initial sessions. The change is no longer a recent treatment, it is part of how the face presents day to day.
Clinical decisions in this period are typically refinement rather than expansion: small dose adjustments, addition of complementary areas if the original plan called for it, and discussion of any concerns that have emerged during the settling process. Conservative practice resists adding new treatment areas without specific clinical indication.
Months 9 to 12: Stabilising the Year and Planning Forward
The final third of the year is about stabilisation and planning. Treatment continues at the standard intervals. Reviews continue to assess the settled effects. Documentation captures the year’s outcomes for comparison against the consultation goals.
This is the period during which the treatment plan is reviewed against the original goals from consultation. Are the goals being met? Has the patient’s view of what they want shifted? Are there areas that have not been treated that should be considered? Are there areas that have been treated that should be reduced or paused?
The answer to these questions shapes the second-year plan. For some patients, year two looks similar to year one with continued treatment of the same areas at the same rhythm. For others, year two involves consolidation (fewer treatments, focused on maintenance) or expansion (additional areas based on the year-one experience). The decision is collaborative and grounded in the year-one documentation.
How Anti-Wrinkle Outcomes Compound Over the Year
The cumulative effect of consistent anti-wrinkle treatment is one of the patterns that the 12-month arc reveals. The first treatment relaxes the muscles. The 12 to 16 weeks until the next treatment allows partial recovery. The second treatment relaxes the muscles again, and so on across the year.
With each cycle, the relative time the muscles spend at reduced activity increases. Over 12 months of consistent treatment, the muscles in the treated areas typically reduce in bulk because chronic activity reduction leads to muscle atrophy. This is a slow change, not visible in any single appointment, but apparent across the 12-month arc.
The practical effect is that static lines (visible at rest, not just during animation) tend to soften across the year. New patients may not see this until their third or fourth treatment. The pattern is one of the reasons conservative practice favours consistent treatment cycles over higher single-session doses.
How Filler Outcomes Develop Across the Year
Filler outcomes develop differently. The volume change is more immediate but the integration with surrounding tissue takes weeks to months. The settled appearance at 6 to 8 weeks is typically the result that endures.
Across 12 months, filler placed in month 1 to 3 reaches its mature settled appearance by month 4 to 6 and remains stable for the rest of the year (and typically beyond). A second filler treatment in month 6 to 9 adds to the foundation, with a similar settling profile.
The duration of effect for filler typically exceeds 12 months for most products and areas. This means that the year-end planning for filler is less about ‘do we need to redo this’ and more about ‘is the original work still appropriate, and where should we go next’. The 12-month review for filler often captures durable results that will continue without intervention into year two.
Why Year Two Looks Different from Year One
Year two is rarely a repeat of year one. The accumulated changes from year one shift the clinical decisions in year two:
Muscle bulk reduction in anti-wrinkle areas means the duration of effect lengthens, so rebooking intervals may extend from 12 to 14 weeks in year one to 14 to 16 weeks in year two.
Filler from year one is typically still in place at the start of year two, so year-two filler decisions are about adding to or refining the existing foundation rather than building from scratch.
The patient’s understanding of their own response has matured. They know how they look at week 2 versus week 8 versus week 14. They know which side of their face responds faster. They can articulate preferences with more clinical specificity. This shapes the year-two consultation conversation.
The practitioner’s documentation provides clinical continuity. Photos and notes from year one inform the year-two technique. Subtle adjustments based on the year-one outcomes refine the approach.
What ‘Done Right’ Looks Like at the 12-Month Mark
The clinical goal at 12 months is not a transformed face. It is a face that looks well-rested, balanced, and consistent with the patient’s natural structure, with subtle softening of lines and modest support of any volume loss that was treated.
For anti-wrinkle treatment, the markers are: reduced static lines compared to the pre-treatment baseline, preserved natural expression range, no asymmetry, and no unintended muscle effects.
For filler, the markers are: subtle volume support, integration with surrounding tissue, no migration, no over-volumisation.
For the patient, the markers are: feeling that the treatment has been worth the time and cost, no regret about specific decisions, willingness to continue with the same practitioner, and a sense that the treatment is part of how they care for themselves rather than a project to be completed.
When the 12-Month Plan Is Not Working
Some 12-month plans do not produce the outcomes the patient or practitioner expected. Reasons include: unrealistic expectations from the consultation that became more apparent as treatment progressed, anatomical factors that are responding differently than predicted, patient preferences that have shifted, or external factors (life changes, health changes) affecting the patient’s relationship with treatment.
When the plan is not working, the appropriate response is to reassess rather than to push forward. The 12-month review is a structured opportunity for that reassessment. Options may include: pausing treatment, switching to a different area, dissolving filler that is not working, or discontinuing treatment altogether.
This is part of conservative practice. The treatment plan is a hypothesis tested against outcomes. Where the hypothesis is wrong, adjustment is the appropriate response, not persistence.
Pricing Across the Year
Pricing for a 12-month plan depends on the treatments delivered. The typical pattern involves: the initial consultation fee, the initial treatment fee, included reviews, and per-appointment fees for subsequent treatments.
Pricing is discussed at consultation and updated at each subsequent treatment. There are no time-limited or discount-based pricing structures, in line with TGA Therapeutic Goods Advertising Code requirements for cosmetic injectable services.
The per-appointment fee depends on the treatment performed at that appointment. Patients have a clear view of the costs at the time of each booking. The cumulative cost across 12 months reflects the cumulative treatment, not a fixed package.
How This Operates at Core Aesthetics
The 12-month arc described on this page is the standard structure of treatment at Core Aesthetics under Corey Anderson, AHPRA registered nurse, NMW0001047575. Each step is documented in the clinical record. Continuity is maintained across appointments by the same practitioner conducting all treatments and reviews.
The approach is conservative, consultation-led, and review-built. Reviews are scheduled at 2 weeks for anti-wrinkle and at appropriate intervals for filler. The 12-month review is the moment to step back and assess the year against the consultation goals.
The goal is not a transformed face. The goal is a face that looks well, supported by treatment that the patient understands and is comfortable continuing. This is the practical outcome of conservative cosmetic injectable practice across the year.
Is this for you?
Consider booking a consultation if
- Patients new to cosmetic injectable treatment and wanting to understand the multi-month structure
- Patients who have had treatment elsewhere and are considering a structured approach for the next year
- Patients curious about what the long-term arc of treatment looks like before committing
- Patients comparing clinics and assessing the structure of treatment plans as part of that decision
This may not be for you if
- Anyone under 18 years of age
- Patients who are pregnant or breastfeeding
- Patients seeking same-day single-session treatment
- Patients seeking guaranteed outcomes, treatment results vary between individuals
- Patients seeking specific clinical advice about an individual treatment plan, this requires individual consultation
Suitability is confirmed at consultation. This list is general guidance, not a substitute for clinical assessment.
Frequently asked questions
How many appointments will I have in the first year?
Typically 4 to 6, depending on which areas are treated. A common pattern is the consultation, the initial treatment, the 2-week review, and 2 to 3 subsequent treatments with their own reviews. Some patients have more if multiple areas are being treated independently. Some have fewer if the plan is focused on a single area.
Will my results be visible after the first appointment?
Yes, but they will be partial and developing. Anti-wrinkle treatment shows the bulk of its effect at 7 to 14 days. Filler shows volume change immediately but integrates with tissue across 4 to 8 weeks. The full treatment outcome develops across multiple appointments rather than appearing in the first session.
Why do I need so many reviews?
Reviews are how the treatment plan stays calibrated. The 2-week review for anti-wrinkle is the appointment where any adjustment is made and where the clinical effect is documented for the next session. Reviews for filler assess settled outcome and any complications. Without reviews, the practitioner has no clinical view of how the treatment is performing, which compromises the quality of subsequent decisions.
What if I want to stop treatment partway through the year?
You can. Cosmetic injectable treatment is elective. There is no obligation to continue. Stopping mid-year produces a recovery curve where anti-wrinkle effects metabolise over weeks and filler effects settle over months. The clinical record captures what was treated and the state at the time of stopping.
Are there discounts for committing to a 12-month plan?
No. TGA Therapeutic Goods Advertising Code prohibits discount-based promotion of cosmetic injectables. Pricing is discussed at consultation and is consistent with the treatment delivered at each appointment. There are no packages or multi-treatment discounts.
How does year two cost compare to year one?
Year two often involves fewer or less intensive treatments because muscle bulk has reduced from year-one consistency and filler from year one is typically still in place. The cumulative cost can be lower in year two than year one for many patients, but this depends on the individual treatment plan.
What happens if I move to another city during the year?
The clinical record is portable. Records can be released to the patient or transferred to another practitioner with the patient’s consent. The new practitioner can continue the plan with the year-one documentation as context. Some discontinuity is inevitable when changing practitioners, but the records support the transition.